Evidence map›Paper›PMID 37415052›Full record

ArticleVirchows Archiv : an international journal of pathology2023

High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology.

Natálie Klubíčková, Elaheh Mosaieby, Nikola Ptáková, Aude Trinquet, Marick Laé, Valérie Costes-Martineau, Alena Skálová

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. ETV6::NTRK3-associated papillary adenocarcinoma: let us play it by ear.Virchows Archiv : an international journal of pathology · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Natálie KlubíčkováDepartment of Pathology, Faculty of Medicine in Pilsen and University Hospital Plzen,, Charles University, Alej Svobody 80, 323 00, Pilsen, Czech Republic. klubickova@biopticka.cz.ORCID http://orcid.org/0000-0002-4407-5544
Elaheh MosaiebyDepartment of Pathology, Faculty of Medicine in Pilsen and University Hospital Plzen,, Charles University, Alej Svobody 80, 323 00, Pilsen, Czech Republic.
Nikola PtákováMolecular-Genetic Laboratory, Bioptical Laboratory, Pilsen, Czech Republic.
Aude TrinquetDepartment of Pathology, Hopital Gui de Chauliac, Montpellier, France.
Marick LaéDepartment of Pathology, Centre Henri Becquerel, Rouen, France.
Valérie Costes-MartineauDepartment of Pathology, Hopital Gui de Chauliac, Montpellier, France.
Alena SkálováDepartment of Pathology, Faculty of Medicine in Pilsen and University Hospital Plzen,, Charles University, Alej Svobody 80, 323 00, Pilsen, Czech Republic.
Charles University · CZHôpital Gui de Chauliac · FRCentre Henri Becquerel

Funding

Ministerstvo Školství, Mládeže a Tělovýchovy SVV260652Univerzita Karlova v Praze Cooperatio Program, research area SURG
6 · The paper itself

Abstract

We report 2 cases of high-grade sinonasal adenocarcinoma with a distinct morphological and immunohistochemical phenotype. Albeit histologically different from secretory carcinoma of the salivary glands, both tumors presented here share an ETV6::NTRK3 fusion. The highly cellular tumors were composed of solid and dense cribriform nests, often with comedo-like necroses in the center, and minor areas with papillary, microcystic, and trabecular formations without secretions, mostly located at the periphery of the lesion. The cells displayed high-grade features, with enlarged, crowded, and often vesicular nuclei with conspicuous nucleoli and brisk mitotic activity. The tumor cells were immunonegative for mammaglobin while showing immunopositivity for p40/p63, S100, SOX10, and GATA3, as well as for cytokeratins 7, 18, and 19. For the first time, we describe 2 cases of primary high-grade non-intestinal type adenocarcinomas of the nasal cavity, distinct from secretory carcinoma by morphology and immunoprofile, harboring the ETV6::NTRK3 fusion.

Indexed as

AdenocarcinomaCarcinomaSalivary Gland NeoplasmsBiomarkers, TumorBreast NeoplasmsETS Translocation Variant 6 ProteinHumansImmunohistochemistryOncogene Proteins, FusionReceptor, trkCBiomarkers, TumorETS Translocation Variant 6 ProteinNTRK3 protein, humanOncogene Proteins, FusionReceptor, trkCETV6::NTRK3Nasal cavitynon-intestinal-type adenocarcinomaSalivary duct carcinomaSecretory carcinomaSinonasal

Identifiers

PMID37415052
PMCPMC10412680
OpenAlexW4383314450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.